{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:56:24Z","timestamp":1781643384721,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Carbapenemase-producing\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    (CP-Ab) is a critical priority pathogen. Between October 2019 and September 2020, a multicentre study was conducted at four Ethiopian hospitals: Tikur Anbessa and Yekatit (central), Hawassa (southern), and Dessie (northern). A total of 1416 sepsis patients were enrolled, and blood cultures were performed.\n                    <jats:italic>Acinetobacter<\/jats:italic>\n                    isolates were confirmed using MALDI-TOF and tested for carbapenem susceptibility. All\n                    <jats:italic>Acinetobacter<\/jats:italic>\n                    isolates were subjected to whole-genome sequencing. Selected isolates underwent nanopore sequencing through Plasmidsaurus. Forty-five\n                    <jats:italic>Acinetobacter<\/jats:italic>\n                    isolates were identified, mostly\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200938), with a few other species (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20097). Among the 38\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    isolates, 18 carried\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>NDM\u22121<\/jats:sub>\n                    and either\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA\u221223<\/jats:sub>\n                    or\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA\u221258<\/jats:sub>\n                    carbapenemase genes concurrently.\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA\u221258<\/jats:sub>\n                    and\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>NDM\u22121<\/jats:sub>\n                    were co-located on plasmids of sizes 80\u00a0kb to 113 kb.\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA\u221266<\/jats:sub>\n                    (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200913) and\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA\u221269<\/jats:sub>\n                    (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200912) were frequently identified chromosomally encoded carbapenemase genes. Several STs of\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    were identified, with ST2 (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200914) and ST1 (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200913) being frequent. One\n                    <jats:italic>A. nosocomialis<\/jats:italic>\n                    carried\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>NDM\u22121<\/jats:sub>\n                    and\n                    <jats:italic>bla<\/jats:italic>\n                    <jats:sub>OXA\u221258<\/jats:sub>\n                    simultaneously. Several other genes were identified that confer resistance to aminoglycosides (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200937), phenicol (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200919), trimethoprim (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200916), macrolides (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200925), quinolones (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200910), tetracyclines (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200922), sulphonamides (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200936), and disinfectants (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200923). The high prevalence of carbapenemase-producing\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    and other\n                    <jats:italic>Acinetobacter<\/jats:italic>\n                    species underscores the need for nationwide antibiotic stewardship.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-44498-1","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:17:56Z","timestamp":1773825476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High magnitude of carbapenemase-producing Acinetobacter baumannii in sepsis patients at Ethiopian referral hospitals: a whole genome analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Melese Hailu","family":"Legese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Asrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adane","family":"Mihret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Aseffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6te","family":"Swedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"44498_CR1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/microorganisms11040875","volume":"11","author":"TV Strateva","year":"2023","unstructured":"Strateva, T. V., Sirakov, I., Stoeva, T. J., Stratev, A. & Peykov, S. Phenotypic and Molecular Characteristics of Carbapenem-Resistant Acinetobacter baumannii Isolates from Bulgarian Intensive Care Unit Patients. Microorganisms 11, 875. https:\/\/doi.org\/10.3390\/microorganisms11040875 (2023).","journal-title":"Microorganisms"},{"key":"44498_CR2","doi-asserted-by":"publisher","first-page":"e1010928","DOI":"10.1371\/journal.ppat.1010928","volume":"19","author":"J Bai","year":"2023","unstructured":"Bai, J., Raustad, N., Denoncourt, J., Van Opijnen, T. & Geisinger, E. Genome-wide phage susceptibility analysis in Acinetobacter baumannii reveals capsule modulation strategies that determine phage infectivity. PLoS Pathog. 19, e1010928. https:\/\/doi.org\/10.1371\/journal.ppat.1010928 (2023).","journal-title":"PLoS Pathog."},{"key":"44498_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/antibiotics13010046","volume":"13","author":"NR Kumar","year":"2024","unstructured":"Kumar, N. R., Balraj, T. A., Kempegowda, S. N. & Prashant, A. Multidrug-Resistant Sepsis: A Critical Healthcare Challenge. Antibiotics 13, 46. https:\/\/doi.org\/10.3390\/antibiotics13010046 (2024).","journal-title":"Antibiotics"},{"key":"44498_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/antibiotics13080784","volume":"13","author":"M Rodr\u00edguez-Aguirregabiria","year":"2024","unstructured":"Rodr\u00edguez-Aguirregabiria, M. et al. Challenges Facing Two Outbreaks of Carbapenem-Resistant Acinetobacter baumannii: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants. Antibiotics 13, 784. https:\/\/doi.org\/10.3390\/antibiotics13080784 (2024).","journal-title":"Antibiotics"},{"key":"44498_CR5","doi-asserted-by":"publisher","unstructured":"Zhang, S., Di, L., Qi, Y., Qian, X. & Wang, S. Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii. Front. Cell. Infect. Microbiol. 14 https:\/\/doi.org\/10.3389\/fcimb.2024.1395260 (2024).","DOI":"10.3389\/fcimb.2024.1395260"},{"key":"44498_CR6","doi-asserted-by":"publisher","unstructured":"Kurihara, M. N. L., Sales, R. O. D., Silva, K. E. D., Maciel, W. G. & Simionatto, S. Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings. Rev. Soc. Bras. Med. Trop. 53 https:\/\/doi.org\/10.1590\/0037-8682-0248-2020 (2020).","DOI":"10.1590\/0037-8682-0248-2020"},{"key":"44498_CR7","doi-asserted-by":"publisher","unstructured":"Lasarte-Monterrubio, C. et al. Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of <\u2009i>bla> <\u2009sub\u2009>\u2009OXA-24\/40<\/sub\u2009>\u2009and Genetic Characterization of the Transmission Mechanism between Acinetobacter Ge. Microbiology Spectrum 10, (2022). https:\/\/doi.org\/10.1128\/spectrum.02734-21","DOI":"10.1128\/spectrum.02734-21"},{"key":"44498_CR8","unstructured":"WHO. WHO Priority Pathogens List for R&D of New Antibiotics. Available online: (2017). http:\/\/www.who.int\/bulletin\/volumes\/94\/9\/16-020916.pdf"},{"key":"44498_CR9","unstructured":"WHO. WHO Bacterial Priority Pathogens List. : bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. 2024, (2024)."},{"key":"44498_CR10","doi-asserted-by":"crossref","unstructured":"Benin, B. M. et al. Carbapenem-induced \u03b2-lactamase-isoform expression trends in <\u2009i>Acinetobacter baumanniiCold Spring Harbor Laboratory, (2024).","DOI":"10.21203\/rs.3.rs-4278273\/v1"},{"key":"44498_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/aac.01512-08","volume":"54","author":"L Poirel","year":"2010","unstructured":"Poirel, L., Naas, T., Nordmann, P. & Diversity Epidemiology, and Genetics of Class D \u03b2-Lactamases. Antimicrob. Agents Chemother. 54, 24\u201338. https:\/\/doi.org\/10.1128\/aac.01512-08 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"44498_CR12","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1099\/jmm.0.000845","volume":"67","author":"U Singkham-in","year":"2018","unstructured":"Singkham-in, U. & Chatsuwan, T. Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand. J. Med. Microbiol. 67, 1667\u20131672. https:\/\/doi.org\/10.1099\/jmm.0.000845 (2018).","journal-title":"J. Med. Microbiol."},{"key":"44498_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jgar.2020.08.014","volume":"23","author":"E Bello-L\u00f3pez","year":"2020","unstructured":"Bello-L\u00f3pez, E. et al. Antibiotic resistance mechanisms in Acinetobacter spp. strains isolated from patients in a paediatric hospital in Mexico. J. Global Antimicrob. Resist. 23, 120\u2013129. https:\/\/doi.org\/10.1016\/j.jgar.2020.08.014 (2020).","journal-title":"J. Global Antimicrob. Resist."},{"key":"44498_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-022-01122-x","volume":"11","author":"MH Legese","year":"2022","unstructured":"Legese, M. H. et al. Sepsis: emerging pathogens and antimicrobial resistance in Ethiopian referral hospitals. Antimicrob. Resist. Infect. Control. 11, 1\u20136. https:\/\/doi.org\/10.1186\/s13756-022-01122-x (2022).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"44498_CR15","unstructured":"Institute, C. L. S. Performance standards for antimicrobial susceptibility testing; 30th ed. CLSI M100 (2020)."},{"key":"44498_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jhin.2017.10.015","volume":"98","author":"WG Maciel","year":"2018","unstructured":"Maciel, W. G. et al. Clonal spread of carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. J. Hosp. Infect. 98, 300\u2013304. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jhin.2017.10.015\u00a0(2018).","journal-title":"J. Hosp. Infect."},{"key":"44498_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jgar.2024.07.017","volume":"38","author":"M Sakuma","year":"2024","unstructured":"Sakuma, M. et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates from a hospital in Nepal. J. Global Antimicrob. Resist. 38, 363\u2013367. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jgar.2024.07.017(2024).","journal-title":"J. Global Antimicrob. Resist."},{"key":"44498_CR18","doi-asserted-by":"publisher","unstructured":"Sewunet, T., Asrat, D., Woldeamanuel, Y., Aseffa, A. & Giske, C. G. Molecular epidemiology and antimicrobial susceptibility of Pseudomonas spp. and Acinetobacter spp. from clinical samples at Jimma medical center, Ethiopia. Front. Microbiol. 13 https:\/\/doi.org\/10.3389\/fmicb.2022.951857 (2022).","DOI":"10.3389\/fmicb.2022.951857"},{"key":"44498_CR19","doi-asserted-by":"publisher","unstructured":"Kitti, T. et al. Genomic relatedness and dissemination of <\u2009i>bla\u2009<\u2009sub\u2009>\u2009NDM-5 among <\u2009i>Acinetobacter baumannii isolated from hospital environments and clinical specimens in Thailand. PeerJ 11, e14831 (2023). https:\/\/doi.org\/10.7717\/peerj.14831","DOI":"10.7717\/peerj.14831"},{"key":"44498_CR20","doi-asserted-by":"publisher","unstructured":"Acolatse, J. E. E. et al. Environmental surveillance of ESBL and carbapenemase-producing gram-negative bacteria in a Ghanaian Tertiary Hospital. Antimicrob. Resist. Infect. Control. 11 https:\/\/doi.org\/10.1186\/s13756-022-01090-2 (2022).","DOI":"10.1186\/s13756-022-01090-2"},{"key":"44498_CR21","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3390\/microorganisms9102104","volume":"9","author":"S Kumar","year":"2021","unstructured":"Kumar, S., Anwer, R. & Azzi, A. Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii. Microorganisms 9, 2104. https:\/\/doi.org\/10.3390\/microorganisms9102104 (2021).","journal-title":"Microorganisms"},{"key":"44498_CR22","doi-asserted-by":"publisher","unstructured":"Simo Tchuinte, P. L. et al. Phenotypic and molecular characterisations of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar. Antimicrob. Resist. Infect. Control. 8 https:\/\/doi.org\/10.1186\/s13756-019-0491-9 (2019).","DOI":"10.1186\/s13756-019-0491-9"},{"key":"44498_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1089\/mdr.2021.0352","volume":"28","author":"SL McKay","year":"2022","unstructured":"McKay, S. L. et al. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in the United States, 2013\u20132017. Microb. Drug Resist. 28, 645\u2013653. https:\/\/doi.org\/10.1089\/mdr.2021.0352 (2022).","journal-title":"Microb. Drug Resist."},{"key":"44498_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jgar.2023.02.019","volume":"33","author":"I Goic-Barisic","year":"2023","unstructured":"Goic-Barisic, I. et al. Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe. J. Global Antimicrob. Resist. 33, 26\u201330. https:\/\/doi.org\/10.1016\/j.jgar.2023.02.019 (2023).","journal-title":"J. Global Antimicrob. Resist."},{"key":"44498_CR25","doi-asserted-by":"publisher","first-page":"e0250896","DOI":"10.1371\/journal.pone.0250896","volume":"16","author":"Z Ayenew","year":"2021","unstructured":"Ayenew, Z. et al. Multidrug resistance pattern of Acinetobacter species isolated from clinical specimens referred to the Ethiopian Public Health Institute: 2014 to 2018 trend anaylsis. PLOS ONE. 16, e0250896. https:\/\/doi.org\/10.1371\/journal.pone.0250896 (2021).","journal-title":"PLOS ONE"},{"key":"44498_CR26","doi-asserted-by":"publisher","first-page":"e0383623","DOI":"10.1128\/spectrum.03836-23","volume":"12","author":"A Santerre Henriksen","year":"2024","unstructured":"Santerre Henriksen, A. et al. In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent \u03b2-lactam\/\u03b2-lactamase inhibitor combinations. Microbiol. Spectr. 12, e0383623. https:\/\/doi.org\/10.1128\/spectrum.03836-23 (2024).","journal-title":"Microbiol. Spectr."},{"key":"44498_CR27","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s40265-021-01580-4","volume":"81","author":"YY Syed","year":"2021","unstructured":"Syed, Y. Y. Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections. Drugs 81, 1559\u20131571. https:\/\/doi.org\/10.1007\/s40265-021-01580-4 (2021).","journal-title":"Drugs"},{"key":"44498_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1017\/ice.2020.35","volume":"41","author":"A Thatrimontrichai","year":"2020","unstructured":"Thatrimontrichai, A. et al. Intervention to reduce carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol. 41, 710\u2013715. https:\/\/doi.org\/10.1017\/ice.2020.35 (2020).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"44498_CR29","doi-asserted-by":"publisher","unstructured":"Chatterjee, S. et al. Carbapenem Resistance in Acinetobacter baumannii and Other Acinetobacter spp. Causing Neonatal Sepsis: Focus on NDM-1 and Its Linkage to ISAba125. Front. Microbiol. 7 https:\/\/doi.org\/10.3389\/fmicb.2016.01126 (2016).","DOI":"10.3389\/fmicb.2016.01126"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44498-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44498-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44498-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:23:53Z","timestamp":1781641433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44498-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44498"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44498-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Department of Microbiology, Immunology, and Parasitology Ethical Review Committee (DEREC\/18\/19\/01-H), the Institutional Review Board (AAUMF 01\u2013008) of the College of Health Sciences, Addis Ababa University, the AHRI\/ALERT Ethics Review Committee (protocol number: P050\/18) of the Armauer Hansen Research Institute, and the National Ethical Review Committee (Ref No. MoSHE\/\/RD\/14.1\/690\/19). Informed consent was obtained from all participants and\/or their parents or legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"14009"}}